jtp 4819 has been researched along with Cerebral Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuo, A; Shinoda, M; Toide, K | 1 |
| Fujiwara, T; Iwamoto, Y; Okamiya, K; Shinoda, M; Toide, K; Uemura, A | 1 |
2 other study(ies) available for jtp 4819 and Cerebral Ischemia
| Article | Year |
|---|---|
Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion.
Topics: Animals; Arginine Vasopressin; Arterial Occlusive Diseases; Avoidance Learning; Brain Ischemia; Cerebral Arteries; Cerebral Cortex; Hippocampus; Learning; Male; Maze Learning; Motor Activity; Protease Inhibitors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Substance P; Thyrotropin-Releasing Hormone | 1996 |
A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Brain Chemistry; Brain Ischemia; Dose-Response Relationship, Drug; Maze Learning; Microdialysis; Neuropeptides; Nootropic Agents; Prolyl Oligopeptidases; Protease Inhibitors; Pyrrolidines; Rats; Serine Endopeptidases | 1997 |